Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)
China · Delayed Price · Currency is CNY 17.65
+0.07 (0.40%)
Oct 28, 2026, 1:34 PM CST
SHA:605016 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,413 | 9,072 | 5,460 | 7,056 | 3,847 | 4,452 | |
Market Cap Growth | -8.07% | 66.15% | -22.61% | 83.41% | -13.59% | - |
Enterprise Value | 7,218 | 8,765 | 5,125 | 6,614 | 3,343 | 3,945 |
Last Close Price | 17.58 | 21.38 | 12.74 | 16.28 | 8.83 | 10.19 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.99 | 24.62 | 22.23 | 36.56 | 25.52 | 42.61 |
Forward PE | 15.20 | 21.54 | 16.00 | 24.14 | 12.33 | 30.20 |
PS Ratio | 4.96 | 6.58 | 4.74 | 8.13 | 5.33 | 6.81 |
PB Ratio | 3.51 | 4.63 | 3.25 | 4.68 | 2.86 | 3.70 |
P/TBV Ratio | 3.54 | 4.66 | 3.29 | 4.72 | 2.89 | 3.75 |
P/FCF Ratio | 901.11 | - | 286.09 | - | - | 110.26 |
P/OCF Ratio | 18.69 | 66.98 | 18.15 | 36.25 | 25.68 | 46.28 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.83 | 6.36 | 4.45 | 7.62 | 4.63 | 6.04 |
EV/EBITDA Ratio | 12.30 | 16.58 | 15.32 | 27.75 | 17.38 | 25.20 |
EV/EBIT Ratio | 14.76 | 20.30 | 19.79 | 34.19 | 22.95 | 35.87 |
EV/FCF Ratio | 877.29 | - | 268.50 | - | - | 97.69 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.22 | 0.12 | 0.01 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.78 | 0.42 | 0.04 | 0.01 | 0.01 | 0.02 |
Debt / FCF Ratio | 55.81 | - | 0.64 | - | - | 0.06 |
Net Debt / Equity Ratio | -0.09 | -0.15 | -0.25 | -0.28 | -0.39 | -0.46 |
Net Debt / EBITDA Ratio | -0.33 | -0.56 | -1.28 | -1.79 | -2.70 | -3.52 |
Net Debt / FCF Ratio | -23.82 | 1.84 | -22.37 | 3.64 | 20.18 | -13.65 |
Asset Turnover | 0.57 | 0.62 | 0.61 | 0.54 | 0.52 | 0.62 |
Inventory Turnover | 3.13 | 3.40 | 4.51 | 3.65 | 3.41 | 4.45 |
Quick Ratio | 1.68 | 2.29 | 2.25 | 2.49 | 5.59 | 9.81 |
Current Ratio | 2.33 | 3.12 | 2.98 | 3.20 | 7.06 | 11.68 |
Return on Equity (ROE) | 20.96% | 20.25% | 15.41% | 13.53% | 11.83% | 11.03% |
Return on Assets (ROA) | 11.74% | 12.13% | 8.59% | 7.50% | 6.61% | 6.49% |
Return on Invested Capital (ROIC) | 22.24% | 25.24% | 19.10% | 17.69% | 17.18% | 15.23% |
Return on Capital Employed (ROCE) | 21.20% | 20.80% | 15.10% | 12.80% | 10.80% | 9.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.56% | 4.06% | 4.50% | 2.73% | 3.92% | 2.35% |
FCF Yield | 0.11% | -1.78% | 0.35% | -1.66% | -0.67% | 0.91% |
Dividend Yield | 1.64% | 1.23% | 1.13% | 0.84% | 0.78% | 0.24% |
Payout Ratio | 29.17% | 25.19% | 31.75% | 16.76% | 7.19% | - |
Buyback Yield / Dilution | 1.97% | 1.09% | -1.26% | -0.12% | -8.63% | -22.70% |
Total Shareholder Return | 3.61% | 2.32% | -0.13% | 0.73% | -7.84% | -22.46% |